On Tuesday 30 October, a Commission spokesperson said that the discussions between representatives of the European Commission and their US counterparts on subjects of regulatory cooperation took place "in a constructive atmosphere".
Issues addressed in Washington the previous week included how to enable trade facilitation in the pharmaceutical sector and that of medical devices, cybersecurity and liquefied natural gas.
The search for ways to reduce the cost of conformity assessments and...